Transcendent Capital Group’s Eli Lilly LLY Stock Holding History

Transcendent Capital Group’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$903K	Sell	780 -45	-5%	-$53.1K	0.36%	59
2026 Q2	$990K	Buy	+825	New	+$843K	0.38%	61
2026 Q1	–	Sell	-195	Closed	-$210K	–	117
2025 Q4	$210K	Buy	+195	New	+$186K	0.09%	114
2025 Q1	–	Sell	-196	Closed	-$151K	–	276
2024 Q4	$151K	Hold	196	–	–	0.08%	113
2024 Q3	$174K	Sell	196 -33	-14%	-$29.7K	0.09%	115
2024 Q2	$207K	Buy	229 +34	+17%	+$27.2K	0.12%	85
2024 Q1	$152K	Hold	195	–	–	0.09%	106
2023 Q4	$114K	Buy	+195	New	+$114K	0.08%	101

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $104B AUM 51.65% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $191B AUM 30.51% 1-Year Est. Return

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $704B AUM 26.74% 1-Year Est. Return

Capital World Investors Los Angeles, California $824B AUM 37.44% 1-Year Est. Return

JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $142B AUM 43.93% 1-Year Est. Return

Primecap Management Pasadena, California $161B AUM 86.05% 1-Year Est. Return

Transcendent Capital Group's LLY Position: Q3 2026 in Review

Transcendent Capital Group reduced its Eli Lilly (LLY) stake by 5.5% in Q3 2026, selling an estimated $53.1K and leaving 780 shares worth $903K. The position accounts for 0.36% of the portfolio, ranked #59.

Transcendent Capital Group first reported a position in LLY in Q4 2023 and has held it in 8 quarters since. The position peaked at $990K in Q2 2026. 3,679 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

Transcendent Capital Group held 780 shares of Eli Lilly worth $903K as of Q3 2026.
Transcendent Capital Group sold 45 Eli Lilly shares in Q3 2026, an estimated $53.1K.
Eli Lilly made up 0.36% of Transcendent Capital Group's portfolio in Q3 2026, its #59 holding.
Transcendent Capital Group first reported a position in Eli Lilly in Q4 2023 and has held it in 8 quarters since.
Transcendent Capital Group's Eli Lilly position peaked at $990K in Q2 2026.
3,679 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on Transcendent Capital Group's 13F filing for Q3 2026, filed 28 Oct 2026.